false

Simon Fleming

Veteran of the pharmaceutical industry, fluent in all aspects of clinical trial management, including business development, strategic operations, process improvement, technology implementation and finance. Special focus on global quality management, data management, biostatistics and statistical programming operations.

• Read: Case Study: Managing Complexity in an Autologous Cell Therapy Trial

  Clinical Trials

  Case Study: Managing Complexity in an Autologous Cell Therapy Trial

  Sep 22, ‘26 | 8 min read

  • 

  • Deborah S.

    Saoussen B.

    Jack S.

  Discover
• Read: How Investigator Engagement Builds Enrollment Momentum

  Clinical Trials

  How Investigator Engagement Builds Enrollment Momentum

  Sep 21, ‘26 | 6 min read

  • 

    Lisa Lopez

  Discover
• Read: Case Study: Nectin 4 Biomarker Testing for Oncology Clinical Programs

  Translational Research

  Case Study: Nectin 4 Biomarker Testing for Oncology Clinical Programs

  Sep 14, ‘26 | 3 min read

  • 

    Christie Bongel

  Discover
• Read: Has the rest of the world finally caught up with Latin America?

  Clinical Trials

  Has the rest of the world finally caught up with Latin America?

  Sep 02, ‘26 | 5 min read

  • 

    Andrés Bayona

  Discover
• Read: Case Study: Rapid Execution of Assay Validation Rescued Global Study

  Translational Research - Assays

  Case Study: Rapid Execution of Assay Validation Rescued Global Study

  Aug 20, ‘26 | 7 min read

  • 

  • Christie B.

    Kennon D.

  Discover
• Read: Clinical AI at Scale: Why Trust Matters More Than Speed

  Clinical Trials

  Clinical AI at Scale: Why Trust Matters More Than Speed

  Aug 18, ‘26 | 6 min read

  • 

  • Zulfat K.

    Shakila J.

    Sugumaran M.

  Discover
• Read: Hidden Strategic Edge in Clinical Trials: Financial Project Management

  Clinical Trials

  Hidden Strategic Edge in Clinical Trials: Financial Project Management

  Aug 17, ‘26 | 5 min read

  • 

    Romy Kane

  Discover
• Read: Why Most Early Autoimmune Trials Fail to Yield Decision-ready Evidence

  Early Phase Research - Autoimmune

  Why Most Early Autoimmune Trials Fail to Yield Decision-ready Evidence

  Aug 10, ‘26 | 6 min read

  • 

    Rui F Duarte-Lopes

  Discover
• Read: Why Global Oncology Evidence May Not Support U.S. Regulatory Approval

  Clinical Trials - Regulatory

  Why Global Oncology Evidence May Not Support U.S. Regulatory Approval

  Aug 03, ‘26 | 9 min read

  • 

    Harpreet Singh, MD

  Discover

Loading...

You've reach the end Back to top